biblio

Export 8 results:
Filters: Author is Kadam, Appasaheb L.  [Clear All Filters]
Journal Article
S. P. Chavan, Kadam, A. L., and Gonnade, R. G., “Enantioselective formal total synthesis of (-)-quinagolide”, Organic Letters, vol. 21, no. 22, pp. 9089-9093, 2019.
S. P. Chavan, Chavan, P. N., Lasonkar, P. B., Khairnar, L. B., and Kadam, A. L., “Facile and convenient synthesis of (+/-)-Biotin via MgCl2/Et3N-mediated C-C coupling and mitsunobu reaction”, Synlett, vol. 25, no. 20, pp. 2879-2882, 2014.
S. P. Chavan, Kawale, S. A., Pisal, M. M., Kadam, A. L., and Gonnade, R. G., “Formal synthesis of (-)-quinagolide: diastereoselective ring expansion via a bicyclic aziridinium ion strategy to access the octahydrobenzo[g]quinoline architecture”, Journal of Organic Chemistry, vol. 86, no. 14, pp. 9344-9352, 2021.
S. P. Chavan, Kadam, A. L., Shinde, S. S., and Gonnade, R. G., “Furan-derived chiral bicycloaziridino lactone synthon: collective syntheses of oseltamivir phosphate (Tamiflu), (S)-pipecolic acid and its 3-hydroxy derivatives”, Chemistry-An Asian Journal, vol. 15, no. 3, pp. 415-424, 2020.
S. P. Chavan, Kawale, S. A., Tripathi, A., Kadam, A. L., and Gonnade, R. G., “Revisiting classical pummerer cyclization reaction: a key strategy for the synthesis of (+/-)-quinagolide”, ChemistrySelect, vol. 7, no. 28, p. e202201600, 2022.
S. P. Chavan, Pawar, A. A., Patil, N. B., Kadam, A. L., and Shinde, S. S., “Scalable synthesis of 3-Ethyl-4-methyl-1,5-dihydro-2H-pyrrol-2-one: an important building block of the antidiabetic drug glimepiride”, Synthesis-Stuttgart, vol. 52, no. 22, pp. 3480-3484, 2020.
S. P. Chavan, Kadam, A. L., Lasonkar, P. B., and Gonnade, R. G., “Synthesis of 3-azidopiperidine skeleton employing ceric ammonium nitrate (CAN)-mediated regioselective azidoalkoxylation of enol ether: total synthesis of d-2 receptor agonist (+/-)-quinagolide”, Organic letters , vol. 20, no. 22, pp. 7011-7014, 2018.
S. P. Chavan, Kadam, A. L., and Kawale, S. A., “Total synthesis of (+/-)-quinagolide: a potent D-2 receptor agonist for the treatment of hyperprolactinemia”, ACS Omega, vol. 4, no. 5, pp. 8231-8238, 2019.